Gene therapy for Stargardt disease associated with ABCA4 gene
- PMID:24664763
- DOI: 10.1007/978-1-4614-3209-8_90
Gene therapy for Stargardt disease associated with ABCA4 gene
Abstract
Mutations in the photoreceptor-specific flippase ABCA4 lead to accumulation of the toxic bisretinoid A2E, resulting in atrophy of the retinal pigment epithelium (RPE) and death of the photoreceptor cells. Many blinding diseases are associated with these mutations including Stargardt's disease (STGD1), cone-rod dystrophy, retinitis pigmentosa (RP), and increased susceptibility to age-related macular degeneration. There are no curative treatments for any of these dsystrophies. While the monogenic nature of many of these conditions makes them amenable to treatment with gene therapy, the ABCA4 cDNA is 6.8 kb and is thus too large for the AAV vectors which have been most successful for other ocular genes. Here we review approaches to ABCA4 gene therapy including treatment with novel AAV vectors, lentiviral vectors, and non-viral compacted DNA nanoparticles. Lentiviral and compacted DNA nanoparticles in particular have a large capacity and have been successful in improving disease phenotypes in the Abca4 (-/-) murine model. Excitingly, two Phase I/IIa clinical trials are underway to treat patients with ABCA4-associated Startgardt's disease (STGD1). As a result of the development of these novel technologies, effective therapies for ABCA4-associated diseases may finally be within reach.
Similar articles
- Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, Zernant-Rajang J, Kan O, Iqball S, Naylor S, Sparrow JR, Gouras P, Allikmets R.Kong J, et al.Gene Ther. 2008 Oct;15(19):1311-20. doi: 10.1038/gt.2008.78. Epub 2008 May 8.Gene Ther. 2008.PMID:18463687Free PMC article.
- Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy.Conley SM, Cai X, Makkia R, Wu Y, Sparrow JR, Naash MI.Conley SM, et al.Biochim Biophys Acta. 2012 Jul;1822(7):1169-79. doi: 10.1016/j.bbadis.2011.10.007. Epub 2011 Oct 13.Biochim Biophys Acta. 2012.PMID:22033104Free PMC article.
- Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration.Lenis TL, Hu J, Ng SY, Jiang Z, Sarfare S, Lloyd MB, Esposito NJ, Samuel W, Jaworski C, Bok D, Finnemann SC, Radeke MJ, Redmond TM, Travis GH, Radu RA.Lenis TL, et al.Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11120-E11127. doi: 10.1073/pnas.1802519115. Epub 2018 Nov 5.Proc Natl Acad Sci U S A. 2018.PMID:30397118Free PMC article.
- Gene Therapy of ABCA4-Associated Diseases.Auricchio A, Trapani I, Allikmets R.Auricchio A, et al.Cold Spring Harb Perspect Med. 2015 Jan 8;5(5):a017301. doi: 10.1101/cshperspect.a017301.Cold Spring Harb Perspect Med. 2015.PMID:25573774Free PMC article.Review.
- Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review.Ghenciu LA, Hațegan OA, Stoicescu ER, Iacob R, Șișu AM.Ghenciu LA, et al.Int J Mol Sci. 2024 Aug 14;25(16):8859. doi: 10.3390/ijms25168859.Int J Mol Sci. 2024.PMID:39201545Free PMC article.Review.
Cited by
- Clinical Observation and Genotype-Phenotype Analysis of ABCA4- Related Hereditary Retinal Degeneration before Gene Therapy.Xiao X, Ye L, Chen C, Zheng H, Yuan J.Xiao X, et al.Curr Gene Ther. 2022;22(4):342-351. doi: 10.2174/1566523222666220216101539.Curr Gene Ther. 2022.PMID:35170407Free PMC article.
- En face OCT in Stargardt disease.Sodi A, Mucciolo DP, Cipollini F, Murro V, Caporossi O, Virgili G, Rizzo S.Sodi A, et al.Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1669-79. doi: 10.1007/s00417-015-3254-1. Epub 2016 Jan 7.Graefes Arch Clin Exp Ophthalmol. 2016.PMID:26743751
- Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision.Karamali F, Behtaj S, Babaei-Abraki S, Hadady H, Atefi A, Savoj S, Soroushzadeh S, Najafian S, Nasr Esfahani MH, Klassen H.Karamali F, et al.J Transl Med. 2022 Dec 7;20(1):572. doi: 10.1186/s12967-022-03738-4.J Transl Med. 2022.PMID:36476500Free PMC article.Review.
- The Ocular Gene Delivery Landscape.Sahu B, Chug I, Khanna H.Sahu B, et al.Biomolecules. 2021 Aug 1;11(8):1135. doi: 10.3390/biom11081135.Biomolecules. 2021.PMID:34439800Free PMC article.Review.
- Molecular Screening of 43 Brazilian Families Diagnosed with Leber Congenital Amaurosis or Early-Onset Severe Retinal Dystrophy.Porto FBO, Jones EM, Branch J, Soens ZT, Maia IM, Sena IFG, Sampaio SAM, Simões RT, Chen R.Porto FBO, et al.Genes (Basel). 2017 Nov 29;8(12):355. doi: 10.3390/genes8120355.Genes (Basel). 2017.PMID:29186038Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials